Evidence map›Paper›PMID 33153814›Full record

ArticleEuropean urology2021

Monitoring Prostate Cancer Incidence Trends: Value of Multiple Imputation and Delay Adjustment to Discern Disparities in Stage-specific Trends.

Scarlett Lin Gomez, Samuel L Washington, Iona Cheng, Franklin W Huang, Matthew R Cooperberg

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in European urology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Scarlett Lin GomezDepartment of Epidemiology and Biostatistics, UCSF, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA, USA; Greater Bay Area Cancer Registry, UCSF, San Francisco, CA, USA. Electronic address: scarlett.gomez@ucsf.edu.
Samuel L WashingtonDepartment of Epidemiology and Biostatistics, UCSF, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA, USA; Department of Urology, UCSF, San Francisco, CA, USA.
Iona ChengDepartment of Epidemiology and Biostatistics, UCSF, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA, USA; Greater Bay Area Cancer Registry, UCSF, San Francisco, CA, USA.
Franklin W HuangHelen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA, USA; Department of Urology, UCSF, San Francisco, CA, USA; San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA; Department of Medicine, UCSF, San Francisco, CA, USA.
Matthew R CooperbergDepartment of Epidemiology and Biostatistics, UCSF, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA, USA; Department of Urology, UCSF, San Francisco, CA, USA; San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.

Funding

NCI NIH HHS HHSN261201800032I
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Prostatic NeoplasmsHumansIncidenceMaleSEER Program

Identifiers

PMID33153814

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.